Story thread · 2 reports / 1 sources
Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more
endpts.com · 3d
How the coverage leans
Across 1 sources · syndicated copies counted once
Welcome back to the Weekly! The Endpoints News team gathered a group of industry experts in Cambridge, MA this week to debate the future of China biotech. During one of the panels, Pfizer’s Andrew Baum ...
First report: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts — endpts.com, 4d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.